Rosetta Genomics

microRNA Clinical News

March 29, 2010

Regulus Therapeutics and Collaborators Publish Pre-clinical In Vivo Efficacy Data on microRNA Therapeutics targeting microRNA-10b in Models of Breast Cancer Metastasis March 29, 2010 8:00 AM EDT – New Paper Published in Nature Biotechnology Reports Therapeutic Efficacy of Targeting miR-10b as a New Anti-Metastatic Agent – CARLSBAD, Calif.–(BUSINESS WIRE)– Regulus Therapeutics Inc. today announced the [...]

Read the full article →

microRNA of the week: microRNA-29

February 19, 2010

There are several groups making headlines that are studying the mir-29 family. Rosetta Genomics Headlines – Joint Study By Rosetta Genomics And NYU Langone Medical Center Identifies Single MicroRNA Biomarker For Prognosis Of Mesothelioma Patients Single microRNA exhibits potential to forecast outcomes of MPM  The results clearly demonstrate that higher levels of miR-29c* in MPM [...]

Read the full article →

microRNA of the Week: microRNA-21

February 5, 2010

5′ – uagcuuaucagacugauguuga – 3′ This week we take a look at an interesting microRNA that has widespread regulatory function and has also been in the headlines of late. microRNA-21 has been linked to a variety of diseases, including cancer, fibrosis, and heart disease and is therefore a potential target for a number of therapeutic [...]

Read the full article →

Next Entries →